ADENOSINE RECEPTORS - TARGETS FOR FUTURE DRUGS
ADENOSINE RECEPTORS - TARGETS FOR FUTURE DRUGS
复制标题
DOI:
10.1021/jm00345a001
复制
发表时间:
1982-01-01
影响因子:
7.3
通讯作者:
DALY, JW
中科院分区:
文献类型:
--
作者:
DALY, JW
The profound hypotensive, sedative, antispasmodic, and vasodilatory actions of adenosine were first recognized over 5 decades ago. 1 During the intervening years the number of biological roles proposed for adenosine and for precursor adenine nucleotides have increased considerably. Extracellular adenosine receptors and adenine nucleotide re-ceptors have been identified. The adenosine receptors appear linked in many cells to adenylate cyclase, while nucleotide receptors probably control ion fluxes. A variety of adenosine analogues and ATP analogues have been introduced in recentyears for the study of these receptor functions. Some of the adenosine analogues are shown in Chart I. Alkylxanthines, such as caffeine and theophyl-line, are the best known antagonists of adenosine receptors. Recently some extremely potent xanthine antagonists have been developed. Some of the adenosine antagonists are depicted in ChartII. There do not appear to be any satisfactory specific ATP-receptor antagonists at the present time.Adenosine perhaps represents a general regulatory substance, since no particular cell type or tissue appears uniquely responsible for its formation. In this regard, adenosine is unlike variousendocrine hormones. Nor is there any evidence for storage and release of adenosine from nerve or other cells. Thus, adenosine is unlike various neurotransmitter substances. The presence of purinergic